Europe is facing the challenge of an expected dramatic increase in the prevalence of cancer that could reach 15 million Europeans by 2020. Health systems will require the promotion of innovative funding and a rethink in regulation, according to a new study released today at the European Health Forum Gastein (EHFG), the European Union's leading health policy congress for experts and…
The biotech industry is being hit twice as hard by the economic crisis. In addition to the general economic downturn, the largely dried-up equity market, which has massively complicated the usual equity financing through the stock exchange or venture capital, is causing problems for companies.
Expert advises specific strategies should be developed to deal with this relatively new patient group.
Incidence data from cancer registries have drawn the attention to colorectal cancer. It is one of the most common cancers in developed countries. In 2006, the estimated number of new cases in the European Union of 25 member states was 297,000 for both genders.
Completion of a Phase I clinical trial has demonstrated the great promise of a completely new type of cancer treatment, according to results announced this June in The New England Journal of Medicine by scientists at the Institute of Cancer Research (ICR) and the Royal Marsden Hospital in the United Kingdom, working with pharma firm AstraZeneca.
Every second geriatric patient acutely hospitalised in Europe suffers malnutrition and, worse, this often goes unnoticed. These shocking facts were aired this July in Paris, during a satellite symposium held by the Nestlé Nutrition Institute at the 19th IAGG World Congress of Gerontology and Geriatrics.
Barcelona, Spain 26-29 November
For the past 30 years, in the former USSR and Russia, laser medicine has been actively developed and regular annual conferences have opened new avenues for its use by the country's doctors.
Four different population-based studies, recently published in Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD), examine a possible link between insulin glargine (brand name, Lantus) and cancer.
As Professor Valentin Fuster pointed out this year, the Centro Nacional de Investigaciones Cardiovasculares (CNIC) is now a splendid reality thanks to the support of the Ministerio de Ciencia y Tecnología and the Instituto de Salud Carlos III institutions on which, now and for the future, it depends. Along with that public sector backing, CNIC will also receive civil support from the ProCNIC…
Charité-Wissenschaftler beschreiben die Rolle des Proteins CTGF Wissenschaftler der Charité - Universitätsmedizin Berlin und des Max-Delbrück Centrums für molekulare Medizin (MDC) in Berlin Buch haben die Funktion des Proteins Connective Tissue Growth Factor (CTGF) im Herzen aufgeklärt.
In the genetic material of cancer cells, important growth inhibitors are often switched off by chemical labels in the DNA. Scientists of the German Cancer Research Center and the Ohio State University, USA, discovered in mice that cancer-typical DNA labeling occurs long before the first symptoms of leukemia appear. A test for the genetic label might therefore help to detect a developing cancer at…
The American Association for Clinical Chemistry (AACC) hosts its 2009 meeting in conjunction with the Canadian Society of Clinical Chemists. Along with this, a high European participation is on the cards. "We are pleased that so many peers from Europe join us each year, and that our European colleagues lead many of the important scientific sessions," said Barbara Goldsmith PhD, current AACC…
In almost all of the industrialised countries, the general health status - as indicated for example by infant mortality, prevalence of disease, subjective health and life expectancy - has improved during the last four decades. At the same time, however, there is a proven close correlation between good and poor health and high and low socioeconomic status.
Newly designed centerpieces used in the Beckman Coulter XL-A and XL-I instruments - the only analytical ultracentrifuges on the market today - allow the systems to provide precise, repeatable measurement of pharmaceutical sample aggregation in pharmaceutical research and formulation laboratories.
The Research Institute of the Hospital Universitari Vall d'Hebron (IR-HUVH) in Barcelona is the first Spanish health centre to acquire the Genome Sequencer FLX System from 454 Life Sciences, a Roche company. This new high-performance sequencing system improves the productivity and precision of genome sequencing at IR-HUVH.
The inflammatory process in the brain of multiple sclerosis patients is triggered by their own immune system. However, there is one type of immune cells that seems to fight against the destructive progress - and might be used for therapeutic purposes in future.
"In-vitro veritas", the slogan of the 18th European Congress of Clinical Chemistry and Laboratory Medicine, which took place in June, underlined the significance of in vitro diagnostics for healthcare, and the presentations by 90 speakers, in 32 scientific sessions and 29 industry sponsored workshops, demonstrated the rich variety of developments.
When a cerebral aneurysm ruptures, mortality is high and survivors often suffer stroke-like long-term disabilities. However, some aneurysms remain stable and never rupture. Surgical and endovascular interventions are possible, but not without risk.
HIV/AIDS has reached pandemic proportions. 35 million people are infected. Given the situation of hard pressed general practitioners (GPs) today, as well as geographical and other difficulties (as in Africa, for example), a new device that will enable HIV patients to monitor their own health and the effectiveness of treatments, without visiting their doctors so often, is indeed promising.
A landmark study has successfully demonstrated a 29 percent reduction in heart failure or death in patients with heart disease who received an implanted cardiac resynchronization therapy device with defibrillator (CRT-D) versus patients who received only an implanted cardiac defibrillator (ICD-only).
WHO has been carefully monitoring the spread of influenza A (H1N1) and has now raised the alert level to level 6. Raising the alert to level 6 is a measure of geographical spread of the virus and not a measure of its severity. At this time, WHO considers the overall severity of the situation to be moderate.
For the 16th year in a row, the innovation prize for radiological diagnostics was awarded by GE Healthcare at this year's Radiology Congress in Berlin. The prize comes with a research budget worth EUR 15,000 and is for young radiologists whose scientific work is opening up new horizons in the field of radiology.
Basic diagnostic x-ray services are a key component of primary health care delivery. However, two-thirds of the world's population is without access to it, according to World Health Organization (WHO) estimates. The WHO further estimates that there is a need for one diagnostic imaging machine for every 50,000 people. The World Health Imaging Alliance announced that it has cemented key…
